|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.310 USD | -2.96% |
|
-1.50% | -28.02% |
| 07-22 | Alzamend Neuro, Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 | CI |
| 07-22 | Alzamend Neuro, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 6.28M 5.46M 5.08M 4.66M 8.81M 599M 8.94M 59.87M 23.5M 298M 23.57M 23.06M 1B | P/E 2027 * |
-0.5x | P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 6.28M 5.46M 5.08M 4.66M 8.81M 599M 8.94M 59.87M 23.5M 298M 23.57M 23.06M 1B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
97.32% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | -2.96% | ||
| 1 week | -1.50% | ||
| 1 month | +9.17% | ||
| 3 months | +14.91% | ||
| 6 months | -39.07% | ||
| Current year | -28.02% |
| 1 week | 1.26 |  | 1.38 |
| 1 month | 1.06 | | 1.38 |
| Current year | 0.84 | | 2.54 |
| 1 year | 0.84 | | 2.68 |
| 3 years | 0.84 | | 634.5 |
| 5 years | 0.84 | | 6,534 |
| 10 years | 0.84 | | 45,292.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephan Jackman
CEO | Chief Executive Officer | 50 | 20/11/2018 |
David Katzoff
DFI | Director of Finance/CFO | 64 | 05/08/2022 |
Henry Nisser
LAW | General Counsel | 57 | 01/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Ault
CHM | Chairman | 56 | 26/02/2016 |
William Horne
CHM | Chairman | 57 | 01/06/2021 |
Stephan Jackman
BRD | Director/Board Member | 50 | 01/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/23/25 A | Sell | Founder | 1,851 | 0.2311% | ||
| 12/23/25 A | Other | Company | 0 | 0% | ||
| 12/19/25 A | Sell | Chairman | 3,333 | 0.4161% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.96% | -1.50% | -41.78% | -99.79% | 6.28M | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +403.17% | +614.40% | 39.87B | |
| -1.16% | +12.96% | +26.45% | +5.03% | 38.68B | |
| -1.88% | -3.03% | +4.94% | +47.52% | 35.13B | |
| -1.74% | +5.12% | +9.58% | +46.02% | 29.79B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.21% | -4.04% | +35.09% | +127.95% | 16.11B | |
| -0.64% | +2.65% | +1.25% | +8.92% | 13.61B | |
| -1.19% | -1.32% | -3.32% | -34.94% | 12.62B | |
| Average | -1.64% | +0.80% | +48.18% | +80.71% | 25.04B | |
| Weighted average by Cap. | -1.60% | +2.03% | +76.86% | +128.09% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -10.8M -9.39M -8.74M -8.02M -15.15M -1.03B -15.39M -103M -40.43M -513M -40.56M -39.67M -1.72B | - |
| Net Debt | - | - |
Employees
5
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $1.310 | -2.96% | 24,817 |
| 30/07/26 | $1.350 | +0.75% | 25,837 |
| 29/07/26 | $1.340 | +2.29% | 18,723 |
| 28/07/26 | $1.310 | -2.24% | 35,069 |
| 27/07/26 | $1.340 | +0.75% | 37,037 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.310USD
Average target price
25.00USD
Spread / Average Target
+1,808.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALZN Stock
Select your edition
All financial news and data tailored to specific country editions
